Noven names new vice president and CMO

In this role, Dr Lippman will lead all aspects of the clinical, regulatory and medical affairs functions at Noven.

Prior to joining Noven, Dr Lippman served Ethicon, a Johnson & Johnson company, as worldwide vice president of medical affairs and chief medical officer and as a member of that company’s global management board.

Dr Lippman holds a medical degree from New York Medical College and a Masters in Public Health from Harvard University School of Public Health.

Peter Brandt, president and CEO of Noven, said: “Dr Lippman’s appointment further expands the industry experience of a Noven team committed to establishing Noven as a high growth specialty pharmaceutical company.”